Untargeted metabolomics of COVID-19 patient serum reveals potential prognostic markers of both severity and outcome (2021)
Attributed to:
Untargeted metabolomics of serum samples during COVID-19 disease progression
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s11306-021-01859-3
PubMed Identifier: 34928464
Publication URI: http://europepmc.org/abstract/MED/34928464
Type: Journal Article/Review
Parent Publication: Metabolomics
Issue: 1
ISSN: 1573-3882